7-Methylguanosine
![]() | |
![]() | |
| Names | |
|---|---|
| IUPAC name
7-Methylguanosine | |
| Other names
N7-Methylguanosine; 2-Amino-1,6-dihydro-7-methyl-6-oxo-9-β-D-ribofuranosylpurinium | |
| Identifiers | |
| 20244-86-4 | |
| Abbreviations | m7G; m7G |
| ChEBI | CHEBI:20794 |
| ChemSpider | 393054 |
| Jmol interactive 3D | Image |
| PubChem | 445404 |
| |
| |
| Properties | |
| C11H16N5O5 | |
| Molar mass | 298.28 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
7-Methylguanosine (m7G) is a modified purine nucleoside. It is a methylated version of guanosine and when found in human urine, it may be a biomarker of some types of cancer. It also plays a role in RNA as blocking group at its 5´-end.[1]
References
- ↑ Reynaud, C; Bruno, C; Boullanger, P; Grange, J; Barbesti, S; Niveleau, A (1992). "Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies". Cancer Letters 61 (3): 255–62. doi:10.1016/0304-3835(92)90296-8. PMID 1739950.
External links
- Metabocard for 7-Methylguanosine (HMDB01107), Human Metabolome Database, University of Alberta
This article is issued from Wikipedia - version of the Saturday, February 13, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

